View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
September 30, 2010

Researchers Develop Blood Test for Colon Cancer

Researchers from Danish biotech company Exiqon have developed a blood test for colon cancer that could be used as an initial screening tool prior to colonoscopy. The test works by measuring the levels of microRNAs, tiny bits of genetic material of tumours in the blood. A study c

By cms admin

Researchers from Danish biotech company Exiqon have developed a blood test for colon cancer that could be used as an initial screening tool prior to colonoscopy.

The test works by measuring the levels of microRNAs, tiny bits of genetic material of tumours in the blood.

A study conducted by the researchers which involved healthy donors and people with early stage colorectal cancer showed that the test was able to identify and rule out colon cancer.

The company plans to conduct a large clinical trial involving patients who are due to have a colonoscopy and those who have colon cancer symptoms.

The company is currently in the first year of its four-year project to develop the colonoscopy test.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management